Xuebin Liu

Xuebin (Leo) Liu currently serves as Vice President and Head of Immuno-Oncology at HDBiosciences Inc, and previously held the position of Executive Director of Immuno-Oncology at the same company. Prior roles include Executive Director at HD Biosciences Co., Ltd., Director of Translational Immuno-Oncology at Crown Bioscience, Inc., Senior Staff at GeneCopoeia, and various roles at GlaxoSmithKline including Associate Director, Manager, and Principal Scientist. Xuebin Liu earned a Ph.D. in Immunology from Beijing Medical University and an M.D. in Science of Medicine from Xinjiang Medical University.